IPO Beckons for Magic Mushroom Research Into Depression

(Bloomberg) -- A health-care investment firm that’s backing studies of magic mushrooms to treat depression raised $25 million of capital and may consider an initial public offering next year, accor...

Bloomberg Quint

Add BloombergQuint App to Home screen.